Bhakta, Savita G.
Chou, Hsun-Hua
Rana, Brinda
Talledo, Jo A.
Balvaneda, Bryan
Gaddis, Laura
Light, Gregory A.
Swerdlow, Neal R.
Funding for this research was provided by:
Sidney R. Baer Jr. Foundation
APF/Merck Early Academic Career Award
Brain & Behavior Research Foundation
VA San Diego Healthcare System, VISN 22, Mental Illness Research, Education & Clinical Center
National Institute of Mental Health (T32 MH018399)
National Cancer Institute (P30CA016056)
Article History
Received: 21 January 2016
Accepted: 1 April 2016
First Online: 13 April 2016
Compliance with ethical standards
:
: Supported by MH059803, MH094320, and MH093453 (NRS, PI). SB and GAL supported by the VISN 22 MIRECC, GAL by the Sidney R. Baer Jr. Foundation and Brain & Behavior Research Foundation, SB and HHC by the Brain & Behavior Research Foundation, SB by the APF Kempf Award, and HHC by the APF/Merck Early Academic Career Award and T32-MH018399. SNP genotyping was performed by the Genomics Shared Resource supported by Roswell Park Cancer Institute and National Cancer Institute (NCI) grant P30CA016056. In the past 3 years, NRS has had support from Neurocrine, Inc. and Genco, Inc., and GAL has received support from Astellas and Forum Pharmaceuticals. Neither NRS nor GAL have ever received support from companies that develop or market memantine. The remaining authors declare no conflict of interest.